MedTrace Logo

Intra-articular Injection of MSCs in Treatment of Knee OA

NCT03028428 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2018-01-30

No results posted yet for this study

Summary

In this study, researchers want to determine the safety of MSCs that a patient can tolerate without causing side effects. Moreover researchers will also be looking at the function of the knee over time, which may give them some insight on the usefulness of MSCs as a treatment option.

Conditions

Interventions

BIOLOGICAL

Placenta Derived Mesenchymal Stem Cell

1ml 1\*10\^7 Placenta Derived Mesenchymal Stem Cell administered into the knee joint once

DRUG

Sodium Hyaluronate

Sodium hyaluronate administered into the knee joint once

Sponsors & Collaborators

  • Affiliated Hospital of Jiangsu University

    lead OTHER

Principal Investigators

  • YU TANG, Dr. · Affiliated Hospital of Jiangsu University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2018-12-31
Completion
2019-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03028428 on ClinicalTrials.gov